tiprankstipranks
Taysha Gene Therapies, Inc. (TSHA)
NASDAQ:TSHA
US Market
TSHA
Taysha Gene Therapies
RESEARCH TOOLSreports

Taysha Gene Therapies (TSHA) Stock News & Sentiment

1,246 Followers
Advancing Gene Therapy Programs and Strengthened Valuation Support Taysha Buy Rating and $17 Target
Premium
Ratings
Advancing Gene Therapy Programs and Strengthened Valuation Support Taysha Buy Rating and $17 Target
5d ago
TSHA
Taysha Gene Therapies Signals Momentum in Earnings Call
Premium
Company Announcements
Taysha Gene Therapies Signals Momentum in Earnings Call
22d ago
TSHA
TSHA Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
TSHA Earnings this Week: How Will it Perform?
1M ago
TSHA
Aehr, Fastenal, Regions, Abeona, Taysha: Insider Firestorm
Premium
Weekend Updates
Aehr, Fastenal, Regions, Abeona, Taysha: Insider Firestorm
2M ago
RF
ABEO
Regulatory Clarity and Broad Rett Syndrome Opportunity Drive Taysha Gene Therapies Buy Rating and $10 Target
Premium
Ratings
Regulatory Clarity and Broad Rett Syndrome Opportunity Drive Taysha Gene Therapies Buy Rating and $10 Target
3M ago
TSHA
Taysha Gene Therapies Advances TSHA-102 Program
Premium
Company Announcements
Taysha Gene Therapies Advances TSHA-102 Program
5M ago
TSHA
Taysha Gene Therapies’ Earnings Call Highlights Progress and Challenges
Premium
Company Announcements
Taysha Gene Therapies’ Earnings Call Highlights Progress and Challenges
5M ago
TSHA
More TSHA News >

TSHA News on the Web

Advancing Gene Therapy Programs and Strengthened Valuation Support Taysha Buy Rating and $17 Target
TipRanks News
Bullish
Taysha Gene Therapies price target raised to $17 from $14 at Canaccord
TipRanks News
Bullish
Analysts Are Bullish on These Healthcare Stocks: HeartFlow, Inc. (HTFL), Taysha Gene Therapies (TSHA)
TipRanks News
Bullish
Taysha Gene Therapies (TSHA) Receives a Buy from Cantor Fitzgerald
TipRanks News
Neutral
Taysha Gene Therapies (TSHA) Receives a Buy from Wells Fargo
TipRanks News
Neutral
Jefferies Reaffirms Their Buy Rating on Taysha Gene Therapies (TSHA)
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Taysha Gene Therapies (TSHA) and Fulcrum Therapeutics (FULC)
TipRanks News
Neutral
BMO Capital Sticks to Their Buy Rating for Taysha Gene Therapies (TSHA)
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
TSHA
Sector Average
Media Buzz
This Week3 articles
Weekly Average4.25 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TSHA’s Media Buzz Sentiment?
3 articles about TSHA were published this week. In an average week, 4.25 articles are published.
    What is TSHA’s weekly average amount of articles?
    In an average week, 4.25 articles about TSHA are published.
      What is TSHA’s News Sentiment?
      100% of articles about TSHA were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        NBIXNeurocrine
        STAAStaar Surgical
        AORTArtivion
        OWLTOwlet
        HUMHumana
        Showing the stocks with the most bullish news sentiment over the past week